Cargando…

Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy

Cancer is the second leading cause of death worldwide. Many dietary plant products show promising anticancer effects. Bitter melon or bitter gourd (Momordica charantia) is a nutrient-rich medicinal plant cultivated in tropical and subtropical regions of many countries. Traditionally, bitter melon is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sur, Subhayan, Ray, Ratna B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464160/ https://www.ncbi.nlm.nih.gov/pubmed/32726914 http://dx.doi.org/10.3390/cancers12082064

Ejemplares similares

Diverse roles of bitter melon (Momordica charantia) in prevention of oral cancer
por: Sur, Subhayan, et al.
Publicado: (2021)

Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium
por: Czompa, Attila, et al.
Publicado: (2017)

A case of atrial fibrillation due to Momordica charantia (bitter melon)
por: Erden, Ismail, et al.
Publicado: (2010)

Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica charantia)
por: Cao, Heping, et al.
Publicado: (2014)

Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia)
por: Cuong, Do Manh, et al.
Publicado: (2018)

Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice
por: Mohammadmoradi, Shayan, et al.
Publicado: (2020)

Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis
por: Semiz, Asli, et al.
Publicado: (2020)

Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products
por: AKYÜZ, Esin, et al.
Publicado: (2020)

Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
por: Nerurkar, Pratibha V, et al.
Publicado: (2011)

Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
por: Nerurkar, Pratibha V, et al.
Publicado: (2010)

The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress
por: Kim, Hyun Young, et al.
Publicado: (2013)

Investigation of Biological Activities of Wild Bitter Melon (Momordica charantia Linn. Var. Abbreviata Ser.)
por: Pham, Thi My Hanh, et al.
Publicado: (2019)

Influence of Total Anthocyanins from Bitter Melon (Momordica charantia Linn.) as Antidiabetic and Radical Scavenging Agents
por: Güdr, Aytaç
Publicado: (2016)

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment
por: , Mahwish, et al.
Publicado: (2021)

Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (Momordica charantia) against Pancreatic Cancer
por: Kandhari, Kushal, et al.
Publicado: (2021)

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
por: Bortolotti, Massimo, et al.
Publicado: (2019)

An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia
por: Poolperm, Sutthaya, et al.
Publicado: (2017)

Bitter Melon (Momordica charantia L.) Rootstock Improves the Heat Tolerance of Cucumber by Regulating Photosynthetic and Antioxidant Defense Pathways
por: Tao, Mei-Qi, et al.
Publicado: (2020)

Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
por: Sur, Subhayan, et al.
Publicado: (2019)

Analysis of the Complete Mitochondrial Genome of the Bitter Gourd (Momordica charantia)
por: Niu, Yu, et al.
Publicado: (2023)

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2011)

Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study
por: Saad, Dalia Yossri, et al.
Publicado: (2017)

Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model
por: Reed, Dominique, et al.
Publicado: (2021)

Correction to: Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
por: Sur, Subhayan, et al.
Publicado: (2019)

Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)
por: Hazarika, Ridip, et al.
Publicado: (2012)

Correction: strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2014)

Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues
por: Bao, Bin, et al.
Publicado: (2013)

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation
por: Zeng, Yanmei, et al.
Publicado: (2018)

Momordica charantia (bitter melon) efficacy and safety on glucose metabolism in Korean prediabetes participants: a 12-week, randomized clinical study
por: Kim, Bukyung, et al.
Publicado: (2022)

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade
por: Yung, Mingo M. H., et al.
Publicado: (2015)

Effects of drying conditions in low‐temperature microwave‐assisted drying on bioactive compounds and antioxidant activity of dehydrated bitter melon (Momordica charantia L.)
por: Nguyen, Thi‐Van‐Linh, et al.
Publicado: (2020)

Potential Biomarkers of Peripheral and Central Fatigue in High-Intensity Trained Athletes at High-Temperature: A Pilot Study with Momordica charantia (Bitter Melon)
por: Kwak, Jae-Jun, et al.
Publicado: (2020)

Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis
por: Matsumura, Hideo, et al.
Publicado: (2014)

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)
por: Mahwish, et al.
Publicado: (2017)

Genome-Wide Analysis of Simple Sequence Repeats in Bitter Gourd (Momordica charantia)
por: Cui, Junjie, et al.
Publicado: (2017)

Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
por: Sur, Subhayan, et al.
Publicado: (2021)

Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars
por: Tsai, Tsung-Hsien, et al.
Publicado: (2014)

Telomere-to-telomere genome assembly of bitter melon (Momordica charantia L. var. abbreviata Ser.) reveals fruit development, composition and ripening genetic characteristics
por: Fu, Anzhen, et al.
Publicado: (2022)

Momordica charantia (Indian and Chinese Bitter Melon) Extracts Inducing Apoptosis in Human Lung Cancer Cell Line A549 via ROS-Mediated Mitochodria Injury
por: Thiagarajan, Siroshini, et al.
Publicado: (2019)

Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia)
por: Kole, Chittaranjan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vbf453kt1h2l1l2p1t2960lvjj